The FNRS Board of Directors has awarded the AMG-Onco 2023 to Michael Herfs, FNRS Qualified Researcher, ULiège, for his project: Impact of human papillomavirus infections on stemness/differentiation properties of cervical junctional cells.
The FNRS Board of Directors has awarded the AMG-Onco 2023 to Michael Herfs, FNRS Qualified Researcher, ULiège, for his project: Impact of human papillomavirus infections on stemness/differentiation properties of cervical junctional cells.
Fund for Scientific Research - FNRS
Rue d’Egmont 5
B - 1000 Bruxelles
Tél : +32 2 504 92 11
BE55 0016 0000 0044